VICENTE
ESTRADA PÉREZ
Profesor titular de universidad
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (17)
2024
-
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection
Journal of Medical Virology, Vol. 96, Núm. 5
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection
International Journal of Molecular Sciences, Vol. 25, Núm. 11
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain
PharmacoEconomics - Open, Vol. 6, Núm. 3, pp. 415-424
2021
-
HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers
AIDS, Vol. 35, Núm. 3, pp. 393-398
-
Low use of condom and high STI incidence among men who have sex with men in PrEP programs
PloS one, Vol. 16, Núm. 2, pp. e0245925
2020
-
Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control
Journal of Molecular Medicine, Vol. 98, Núm. 8, pp. 1093-1105
2019
-
CD4 recovery is associated with genetic variation in IFNγ and IL19 genes
Antiviral Research, Vol. 170
-
Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study)
Clinical Infectious Diseases, Vol. 68, Núm. 1, pp. 120-130
2018
-
CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control
Scientific Reports, Vol. 8, Núm. 1
2017
-
Peripheral T follicular helper Cells Make a Difference in HIV Reservoir Size between Elite Controllers and Patients on Successful cART
Scientific Reports, Vol. 7, Núm. 1
2014
2008
-
Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease
HIV Clinical Trials, Vol. 9, Núm. 2, pp. 83-90
2005
-
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load
HIV Medicine, Vol. 6, Núm. 5, pp. 353-359
2004
-
Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load
Clinical Infectious Diseases, Vol. 39, Núm. 7, pp. 1024-1029
-
Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors
HIV Medicine, Vol. 5, Núm. 2, pp. 128-129